Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data

19 Apr 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Inflammasome and immune disorders
Share to interferon and immune responses

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33887367
DOI: 10.1016/j.gene.2021.145665

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic dataPMID 33887367Read ↗

Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection.Semantic proximity Read ↗

A unique dexamethasone-dependent gene expression profile in the lungs of COVID-19 patientsSemantic proximity Read ↗

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read ↗

A single-cell transcriptomic landscape of the lungs of patients with COVID-19Semantic proximity Read ↗

An Immune Cell Atlas Reveals Dynamic COVID-19 Specific Neutrophil Programming Amenable to Dexamethasone TherapySemantic proximity Read ↗

Insights into glucocorticoid responses derived from omics studiesSemantic proximity Read ↗

COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and may be modified by dexamethasoneSemantic proximity Read ↗

WITHDRAWN: A gene expression-based diagnostic classifier for identification of severe COVID-19 and multisystem inflammatory syndrome in children (MIS-C)Semantic proximity Read ↗

RNA-Seq Analysis of Activated PBMC Treated With LMWF5A Predicts an Anti-Inflammatory Mode of Action and Similar Drug Targets to DexamethasoneSemantic proximity Read ↗

COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasoneSemantic proximity Read ↗

Comparative Effectiveness of Dexamethasone in Treatment of Hospitalized COVID-19 Patients during the First Year of the Pandemic: The N3C Data RepositorySemantic proximity Read ↗

COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe casesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.